Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
In surprise, FDA approves UroGen's chemo-turned-gel drug after negative adcomm vote
44 minutes ago
FDA+
Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases
2 hours ago
R&D
FDA+
RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone
18 hours ago
FDA+
Trump officials seek price details and weigh consumer sales as they examine most favored nation plan
22 hours ago
Trump’s HHS urges against reviving Chamber of Commerce’s IRA lawsuit
22 hours ago
Law
Federal officials schedule three listening sessions this summer to address drug competition
22 hours ago
Nuvation Bio scores first FDA approval for new lung cancer drug
Yesterday
FDA+
Have sky-high sales projections set the obesity market up to fail?
Yesterday
In Focus
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
Yesterday
People
Cell/Gene Tx
Argenx says its drug Vyvgart looks promising in two more autoimmune diseases
Yesterday
R&D
FDA’s Makary says he wasn’t part of decision to gut ACIP, defers possible VRBPAC changes to Prasad
Yesterday
R&D
FDA+
GoodRx goes toe-to-toe with Hims, Ro as it pushes into ED treatment
2 days ago
Health Tech
Updated: HHS chief Kennedy removes all ACIP members, dismantling vaccine board
2 days ago
FDA+
FDA adds biomarker limits to stomach, esophageal cancer labels for Merck's Keytruda and BMS' Opdivo
2 days ago
FDA+
Updated: Merck wins FDA approval for RSV antibody drug, making a hot market more competitive
3 days ago
R&D
FDA+
In a break from other biotechs, Twist Bioscience throws support behind tariffs on synthetic DNA
3 days ago
Manufacturing
Sanofi leans into 'first-mover advantage' by shipping Beyfortus early, as RSV antibody market set to heat up
3 days ago
Manufacturing
EMA considers serious eye condition a ‘very rare’ side effect of semaglutide
5 days ago
FDA+
Pharma imports into the US return to normal after March tariff stockpiling
6 days ago
Manufacturing
Biotech ranks as China’s best shot to surpass US in emerging tech, report finds
6 days ago
China
A decade after its ill-fated $40.5B megadeal, Teva pivots from generics to innovation
Last week
R&D
Anne Wojcicki and Regeneron set to duke it out in restarted 23andMe auction
Last week
Deals
Exclusive: After cutting most staff, Casma eyes path to clinic with its first autophagy-boosting drug
Last week
R&D
Ex-HHS workers accuse Trump administration of using flawed data to issue firings
Last week
People
Law
1
2
3
4
Next page
Last page